Biolinerx, Ltd
- Investor (buy-side or sell-side research)
- Biotech or pharma, animal health
A biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. Recently developed and launched FDA-approved APHEXDA® for SCM for autologous transplantation in MM. BioLineRx is actively seeking partnership opportunities with companies developing late-preclinical (up to 1 year from IND) or clinical-stage small molecules and peptides in the fields of oncology and rare diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}